Literature DB >> 16652346

Maxillary ameloblastic carcinoma in a child.

Nalan Yazici1, Begül Karagöz, Ali Varan, Taner Yilmaz, Arzu Oztürk, Alp Usubütün, Münevver Büyükpamukçu.   

Abstract

We report an extremely rare occurrence of ameloblastic carcinoma located in the maxilla of a pediatric patient. Wide surgical resection was done along with adjuvant radiotherapy because of involved surgical margins. Histopathological diagnosis was established with morphological features of both ameloblastoma and carcinoma. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh：

Year:  2008        PMID： 16652346     DOI： 10.1002/pbc.20889

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  5 in total

Review 1.  Ameloblastoma: a clinical review and trends in management.

Authors:  Andrew C McClary; Robert B West; Ashley C McClary; Jonathan R Pollack; Nancy J Fischbein; Christopher F Holsinger; John Sunwoo; A Dimitrios Colevas; Davud Sirjani
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-30       Impact factor: 2.503

Review 2.  New classification of maxillary ameloblastic carcinoma based on an evidence-based literature review over the last 60 years.

Authors:  Astrid L D Kruse; Roger A Zwahlen; Klaus W Grätz
Journal:  Head Neck Oncol       Date:  2009-08-12

3.  Ameloblastic carcinoma: A clinicopathologic dilemma - Report of two cases with total review of literature from 1984 to 2012.

Authors:  Indu Bhusan Kar; R V Subramanyam; Niranjan Mishra; Akhilesh Kumar Singh
Journal:  Ann Maxillofac Surg       Date:  2014-01

4.  Primary ameloblastic carcinoma of the maxilla: A case report and literature review.

Authors:  Narikazu Uzawa; Miho Suzuki; Chika Miura; Nobuyoshi Tomomatsu; Toshiyuki Izumo; Kiyoshi Harada
Journal:  Oncol Lett       Date:  2014-10-31       Impact factor: 2.967

5.  Ameloblastic carcinoma: An analysis of 12 cases with a review of the literature.

Authors:  Jia Li; Hongming DU; Peng Li; Jingkui Zhang; Weidong Tian; Wei Tang
Journal:  Oncol Lett       Date:  2014-06-05       Impact factor: 2.967
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.